Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Papillomavirus Infections × Artesunate × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Intestinal Neoplasms 2 Papillomavirus Infections 1 Malaria 1 Lymphoma, Follicular 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 CIN 2/3 1 Breast Neoplasms 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 34 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26 Papillomavirus Vaccines 21 Vaccines 11 Human Papillomavirus Recombinant Vaccine nonavalent 10 Human Papillomavirus DNA Tests 7 Colposcopy 7 Radiotherapy, Intensity-Modulated 6 Cisplatin 6 Carboplatin 6 Vaccines, Synthetic 5 Specimen Handling 5 Educational Status 5 Vaginal Smears 4 Engerix-B 4 Early Intervention, Educational 4 Blood Specimen Collection 4 fludarabine 3 artesunic acid 3 artemisinin 3 Watchful Waiting 3 Surveys and Questionnaires 3 Methods 3 Imiquimod 3 Hepatitis A Vaccines 3 Cyclophosphamide 3 halofantrine 2 fludarabine phosphate 2 artenimol 2 aldesleukin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡